BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 11547216)

  • 1. Endothelial dysfunction and type 2 diabetes. Part 1: physiology and methods for exploring the endothelial function.
    Guerci B; Kearney-Schwartz A; Böhme P; Zannad F; Drouin P
    Diabetes Metab; 2001 Sep; 27(4 Pt 1):425-34. PubMed ID: 11547216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endothelial dysfunction and type 2 diabetes. Part 2: altered endothelial function and the effects of treatments in type 2 diabetes mellitus.
    Guerci B; Böhme P; Kearney-Schwartz A; Zannad F; Drouin P
    Diabetes Metab; 2001 Sep; 27(4 Pt 1):436-47. PubMed ID: 11547217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Why does diabetes mellitus increase the risk of cardiovascular disease?
    Shahab A
    Acta Med Indones; 2006; 38(1):33-41. PubMed ID: 16479030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Von Willebrand factor in diabetic angiopathy.
    Kessler L; Wiesel ML; Attali P; Mossard JM; Cazenave JP; Pinget M
    Diabetes Metab; 1998 Sep; 24(4):327-36. PubMed ID: 9805643
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The endothelial dysfunction in diabetes mellitus.
    Pănuş C; Moţa M; Vladu D; Vanghelie L; Răducanu CL
    Rom J Intern Med; 2003; 41(1):27-33. PubMed ID: 15529582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endothelial dysfunction in obesity and insulin resistance: a road to diabetes and heart disease.
    Caballero AE
    Obes Res; 2003 Nov; 11(11):1278-89. PubMed ID: 14627747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of troglitazone, an insulin-sensitizing agent, on the endothelial function in early and late type 2 diabetes: a placebo-controlled randomized clinical trial.
    Caballero AE; Saouaf R; Lim SC; Hamdy O; Abou-Elenin K; O'Connor C; Logerfo FW; Horton ES; Veves A
    Metabolism; 2003 Feb; 52(2):173-80. PubMed ID: 12601628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endothelial dysfunction in diabetes mellitus.
    Cosentino F; Lüscher TF
    J Cardiovasc Pharmacol; 1998; 32 Suppl 3():S54-61. PubMed ID: 9883749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Myocardial and coronary vessel dysfunction in diabetes I patients].
    Konduracka E; Galicka-Latała D; Piwowarska W; Sieradzki J
    Przegl Lek; 2002; 59(7):514-8. PubMed ID: 12516240
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lifestyle modification and endothelial function in obese subjects.
    Hamdy O
    Expert Rev Cardiovasc Ther; 2005 Mar; 3(2):231-41. PubMed ID: 15853597
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin resistance and endothelial dysfunction: the road map to cardiovascular diseases.
    Cersosimo E; DeFronzo RA
    Diabetes Metab Res Rev; 2006; 22(6):423-36. PubMed ID: 16506274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypoglycemic pharmacological treatment of type 2 diabetes: targeting the endothelium.
    Nathanson D; Nyström T
    Mol Cell Endocrinol; 2009 Jan; 297(1-2):112-26. PubMed ID: 19038307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Obesity impairs vascular relaxation in human subjects: hyperglycemia exaggerates adrenergic vasoconstriction arterial dysfunction in obesity and diabetes.
    Sivitz WI; Wayson SM; Bayless ML; Sinkey CA; Haynes WG
    J Diabetes Complications; 2007; 21(3):149-57. PubMed ID: 17493547
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [HIV infection, antiretroviral therapy, and endothelium].
    Hürlimann D; Weber R; Enseleit F; Lüscher TF
    Herz; 2005 Sep; 30(6):472-80. PubMed ID: 16170677
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endothelial dysfunction in diabetes mellitus.
    Schiekofer S; Balletshofer B; Andrassy M; Bierhaus A; Nawroth PP
    Semin Thromb Hemost; 2000; 26(5):503-11. PubMed ID: 11129406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of measures of endothelial function to stratify risk.
    Charbonneau F
    Can J Cardiol; 2001 May; 17 Suppl A():18A-21A. PubMed ID: 11381290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endothelial dysfunction, atherosclerosis and diabetes.
    Najemnik C; Sinzinger H; Kritz H
    Acta Med Austriaca; 1999; 26(5):148-53. PubMed ID: 11512191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coenzyme Q(10) improves endothelial dysfunction of the brachial artery in Type II diabetes mellitus.
    Watts GF; Playford DA; Croft KD; Ward NC; Mori TA; Burke V
    Diabetologia; 2002 Mar; 45(3):420-6. PubMed ID: 11914748
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endothelial dysfunction in type 2 diabetes: effect of antioxidants.
    Sena CM; Nunes E; Louro T; Proença T; Seiça RM
    Rev Port Cardiol; 2007 Jun; 26(6):609-19. PubMed ID: 17849945
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms of Disease: endothelial dysfunction in insulin resistance and diabetes.
    Rask-Madsen C; King GL
    Nat Clin Pract Endocrinol Metab; 2007 Jan; 3(1):46-56. PubMed ID: 17179929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.